Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia-Reference-Cited by-同舟云学术

Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia

Published:2016-04-06 Issue:5 Volume:38 Page:781-786
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Okuturlar Yildiz,Akalin Nilgul,Kaptanogullari Ozlem Harmankaya,Guner Nurten Turan,Yilmaz Deniz,Gedikbasi Asuman,Soyluk Ozlem,Mert Meral,Serin Sibel Ocak,Kocoglu Hakan,Hursitoglu Mehmet,Kumbasar Abdulbaki

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2016.1162080

Reference36 articles.

1. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study

2. Anemia of end-stage renal disease (ESRD)

3. Iron Status and Hemoglobin Level in Chronic Renal Insufficiency

4. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

5. Anemia and cardiovascular and kidney disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis;Journal of Clinical Medicine;2023-02-02

2. Clinical significance of serum hepcidin in the diagnosis and treatment of patients with anemia of chronic disease: a meta-analysis;Biomarkers;2021-03-02

3. Arylesterase activity but not PCSK9 levels is associated with chronic kidney disease in type 2 diabetes;International Urology and Nephrology;2020-07-13

4. Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease;Antioxidants;2019-07-30